Evidence map›Paper›PMID 32982487›Full record

ArticleJournal of experimental pharmacology2020

Chemo Suppressive and Curative Potential of

Desye Misganaw, Gedefaw Getnet Amare, Getnet Mengistu

Abstract read
In one paragraph

Article in Journal of experimental pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. mBio · 2024
    Article
  4. Article
  5. Frontiers in pharmacology · 2024
    Article
  6. Review
  7. Heliyon · 2023
    Article
  8. Article
  9. The Pan African medical journal · 2023
    Article
  10. Article
  11. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Suppressive, Curative, and Prophylactic Effects ofBioMed research international · 2022
    Article
  13. Heliyon · 2021
    Article
  14. Review
  15. Antiplasmodial Activity of the Crude Extract and Solvent Fractions of Stem Barks ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  16. Antimalarial Activity ofJournal of experimental pharmacology · 2020
    Article
  17. Synergistic Interaction of Chloroquine withIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Desye MisganawPharmacology and Toxicology Unit, Department of Pharmacy, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Gedefaw Getnet AmarePharmacology and Toxicology Unit, Department of Pharmacy, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0002-8356-7357
Getnet MengistuPharmacology and Toxicology Unit, Department of Pharmacy, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0002-8367-5315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of drug resistance together with the global burden of malaria triggers the necessity for the searching of new antimalarial agents. This study, therefore, was initiated to investigate the in vivo antimalarial activity of

methodsThe 4-day suppressive (crude extract and fractions) and the Rane's (n-butanol fraction) tests were used to evaluate the antimalarial activity of the plant. A cold maceration technique with 80% methanol was used for the crude extraction of the plant. The crude extract was then fractionated using solvents of different polarity (chloroform, n-butanol, and water).

resultsAll the test doses of the crude extract as well as the fractions reduced parasitemia and prolonged mean survival time significantly (

conclusionThe study has revealed that the plant has a promising antimalarial activity, the activity being more in the crude extract than the fractions. The highest antimalarial activity of the n-butanol fraction suggests that non-polar and medium polar principles could be responsible for the observed activity.

Indexed as

antimalarial activityHypoestes forskaleiparasitemiaPlasmodium berghei

Identifiers

PMID32982487
PMCPMC7498819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.